Drug Shortage Report for OXYTOCIN INJECTION USP

Last updated on 2024-04-25 History
Report ID 169271
Drug Identification Number 00497398
Brand name OXYTOCIN INJECTION USP
Common or Proper name OXYTOCIN INJECTION USP
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) OXYTOCIN
Strength(s) 10UNIT
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR
Packaging size 10 x 1mL amp
ATC code H01BB
ATC description POSTERIOR PITUITARY LOBE HORMONES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-01-16
Estimated end date 2024-05-27
Actual end date
Shortage status Actual shortage
Updated date 2024-04-25
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2023-01-04 English Compare
v11 2023-01-03 English Compare
v10 2022-11-10 French Compare
v9 2022-11-10 English Compare
v8 2022-11-10 English Compare
v7 2022-10-11 French Compare
v6 2022-10-11 English Compare
v5 2022-10-02 English Compare
v4 2022-09-30 French Compare
v3 2022-09-30 English Compare
v2 2022-09-15 French Compare
v1 2022-09-15 English Compare

Showing 21 to 32 of 32